Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC14H9NO4 |
InChIKeyODBKWEKEHDSOEU-UHFFFAOYSA-N |
CAS Registry2416167-64-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | KR | 24 May 2021 |